Floatz logo

FILGRASTIM

Beta Thalassemia Major

Beni-Suef Universityprotein_peptidePhase 2/3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Beta Thalassemia Major cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
M.D. Anderson Cancer Center
Phase 2BB
AMLODIPINE
Tanta University
Phase 2/3B
Sofosbuvir
Ain Shams University
Phase 3B
Ledipasvir
Ain Shams University
Phase 3B
Emeramide
EmeraMed
Phase 2B

View all 14 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →